type here...

CATEGORIES

Press Release

LATEST

Editors Choice

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Medika Life -
Press Release

MITRE-Harris Poll Survey Finds Half of Patients in the US Feel Ignored or Doubted When Seeking Medical Treatment

Medika Life -
Digital Health

First “Global State of Digital Health Report” Tapping into 200 Million Data Points Examines More Than 12,000 Digital Health Ventures Now Available

Medika Life -
Press Release

Cumulus Neuroscience Appoints Digital Health and Pharma Executive Aman Bhatti, MD as Chief Executive Officer

Medika Life -
Anxiety and Depression

U.S. Prepares Launch of a National Three-Digit Number for the Mental Health Crisis Hotline

Medika Life -
Press Release

Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience

Medika Life -
Press Release

Largest Coordinated HIV Testing Event in the Nation on June 27th

Medika Life -
Press Release

Galien Foundation Announces New Prix Galien Award Category, “Incubators, Accelerators and Equity – Foundational Support for Health Innovation”

Medika Life -
For Doctors

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained

Medika Life -
Press Release

Cogitativo Joins the Veterans Health Administration to Address the Deferred Care Challenge Using AI-Enabled Solution

Medika Life -
123...12Page 2 of 12

TRENDING

EDITORS CHOICE

Coronavirus: FDA Authorizes First Point-of-Care Antibody Test

Medika Life -
The Assure COVID-19 IgG/IgM Rapid Test Device is currently the only FDA authorized COVID-19 POC serology test and is available by prescription only.

The 50 Most Influential Leaders in Pharmacy Awards Opens for Nominations

Medika Life -
Nominations for the 50 most influential individuals in Pharma are now open. Join the Pharmacy Podcast Network in celebrating your choices

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Experimental Drug Blocks COVID-19 Viral Entry into Lung Cells

Medika Life -
An experimental compound prevents the virus that causes COVID-19 from entering human airway cells, a new study finds.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories